blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1240161

EP1240161 - THIENYLALANINE DERIVATIVES AS INHIBITORS OF CELL ADHESION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.02.2008
Database last updated on 03.10.2024
Most recent event   Tooltip11.09.2009Lapse of the patent in a contracting state
New state(s): TR		published on 14.10.2009  [2009/42]
Applicant(s)For all designated states
Aventis Pharma Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
[N/P]
Former [2008/38]For all designated states
Aventis Pharma Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
For all designated states
Genentech, Inc.
1 DNA Way
South San Francisco CA 94080-4990 / US
Former [2002/38]For all designated states
Aventis Pharma Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
For all designated states
Genentech Inc.
1 DNA Way
South San Francisco, CA 94080-4990 / US
Inventor(s)01 / GADEK, Thomas
2838 Chelsea Drive
Oakland, CA 94611 / US
02 / GOURVEST, Jean-François
12, rue de-la-Biberonne
F-77410 Claye Souilly / FR
03 / PEYMAN, Anuschirwan
Zeilsheimer Strasse 46
65779 Kelkheim / DE
04 / RUXER, Jean-Marie
12, Esplanade de la Manufacture
F-92130 Issy les Moulineaux / FR
05 / SCHEUNEMANN, Karl-Heinz
Im Kohlruss 25
65835 Liederbach / DE
 [2002/38]
Representative(s)Vieillefosse, Jean-Claude, et al
Hirsch & Associés
58, Avenue Marceau
75008 Paris / FR
[N/P]
Former [2004/49]Vieillefosse, Jean-Claude, et al
Cabinet Hirsch 58, avenue Marceau
75008 Paris / FR
Former [2002/38]Rousseau, Pierrick Edouard, et al
Aventis Pharma S.A. Département des Brevets, 102, Route de Noisy
93235 Romainville Cedex / FR
Application number, filing date00989987.312.12.2000
[2002/38]
WO2000EP12877
Priority number, dateEP1999012497115.12.1999         Original published format: EP 99124971
[2002/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0144237
Date:21.06.2001
Language:EN
[2001/25]
Type: A1 Application with search report 
No.:EP1240161
Date:18.09.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 21.06.2001 takes the place of the publication of the European patent application.
[2002/38]
Type: B1 Patent specification 
No.:EP1240161
Date:18.04.2007
Language:EN
[2007/16]
Search report(s)International search report - published on:EP21.06.2001
ClassificationIPC:C07D409/12, A61K31/505, A61P19/08, A61P19/10
[2002/38]
CPC:
C07D409/12 (EP,US); A61P19/08 (EP); A61P19/10 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/38]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:THIENYLALANINDERIVATE ALS INHIBITOREN DER ZELLADHÄSION[2002/50]
English:THIENYLALANINE DERIVATIVES AS INHIBITORS OF CELL ADHESION[2002/38]
French:DERIVES DE THIENYLALANINE INHIBITEURS D'ADHESION CELLULAIRE[2002/38]
Former [2002/38]THIENYLALANINDERIVATIE ALS INHIBITOREN DER ZELLADHÄSION
Entry into regional phase15.07.2002National basic fee paid 
15.07.2002Designation fee(s) paid 
15.07.2002Examination fee paid 
Examination procedure21.06.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
15.07.2002Examination requested  [2002/38]
26.04.2004Despatch of a communication from the examining division (Time limit: M06)
27.09.2004Reply to a communication from the examining division
14.03.2005Despatch of a communication from the examining division (Time limit: M06)
08.08.2005Reply to a communication from the examining division
21.10.2005Despatch of a communication from the examining division (Time limit: M06)
18.04.2006Reply to a communication from the examining division
28.09.2006Communication of intention to grant the patent
08.02.2007Fee for grant paid
08.02.2007Fee for publishing/printing paid
Opposition(s)21.01.2008No opposition filed within time limit [2008/13]
Fees paidRenewal fee
02.01.2003Renewal fee patent year 03
29.12.2003Renewal fee patent year 04
24.12.2004Renewal fee patent year 05
27.12.2005Renewal fee patent year 06
27.12.2006Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.12.200203   M06   Fee paid on   15.02.2003
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT18.04.2007
BE18.04.2007
CH18.04.2007
CY18.04.2007
DK18.04.2007
FI18.04.2007
IT18.04.2007
LI18.04.2007
NL18.04.2007
TR18.04.2007
SE18.07.2007
GR19.07.2007
ES29.07.2007
PT18.09.2007
IE12.12.2007
LU12.12.2007
MC31.12.2007
[2009/42]
Former [2009/37]AT18.04.2007
BE18.04.2007
CH18.04.2007
CY18.04.2007
DK18.04.2007
FI18.04.2007
IT18.04.2007
LI18.04.2007
NL18.04.2007
SE18.07.2007
GR19.07.2007
ES29.07.2007
PT18.09.2007
IE12.12.2007
LU12.12.2007
MC31.12.2007
Former [2009/33]AT18.04.2007
BE18.04.2007
CH18.04.2007
CY18.04.2007
DK18.04.2007
FI18.04.2007
IT18.04.2007
LI18.04.2007
NL18.04.2007
SE18.07.2007
GR19.07.2007
ES29.07.2007
PT18.09.2007
IE12.12.2007
MC31.12.2007
Former [2008/48]AT18.04.2007
BE18.04.2007
CH18.04.2007
DK18.04.2007
FI18.04.2007
IT18.04.2007
LI18.04.2007
NL18.04.2007
SE18.07.2007
GR19.07.2007
ES29.07.2007
PT18.09.2007
IE12.12.2007
MC31.12.2007
Former [2008/33]AT18.04.2007
BE18.04.2007
CH18.04.2007
DK18.04.2007
FI18.04.2007
IT18.04.2007
LI18.04.2007
NL18.04.2007
SE18.07.2007
GR19.07.2007
ES29.07.2007
PT18.09.2007
MC31.12.2007
Former [2008/23]AT18.04.2007
BE18.04.2007
CH18.04.2007
DK18.04.2007
FI18.04.2007
IT18.04.2007
LI18.04.2007
NL18.04.2007
SE18.07.2007
GR19.07.2007
ES29.07.2007
PT18.09.2007
Former [2008/19]AT18.04.2007
BE18.04.2007
CH18.04.2007
DK18.04.2007
FI18.04.2007
LI18.04.2007
NL18.04.2007
SE18.07.2007
GR19.07.2007
ES29.07.2007
PT18.09.2007
Former [2008/09]AT18.04.2007
BE18.04.2007
CH18.04.2007
DK18.04.2007
FI18.04.2007
LI18.04.2007
NL18.04.2007
SE18.07.2007
ES29.07.2007
PT18.09.2007
Former [2008/08]AT18.04.2007
BE18.04.2007
CH18.04.2007
DK18.04.2007
FI18.04.2007
LI18.04.2007
SE18.07.2007
ES29.07.2007
PT18.09.2007
Former [2008/04]AT18.04.2007
BE18.04.2007
CH18.04.2007
FI18.04.2007
LI18.04.2007
SE18.07.2007
ES29.07.2007
PT18.09.2007
Former [2007/50]AT18.04.2007
CH18.04.2007
FI18.04.2007
LI18.04.2007
SE18.07.2007
ES29.07.2007
PT18.09.2007
Former [2007/48]CH18.04.2007
FI18.04.2007
LI18.04.2007
SE18.07.2007
ES29.07.2007
PT18.09.2007
Former [2007/47]ES29.07.2007
Cited inInternational search[DY]EP0528587  (MERCK & CO INC [US]) [DY] 1,6-9 * examples 2-5; claims 1,6,7 *;
 [DY]WO9408577  (MERCK & CO INC [US], et al) [DY] 1,6-9 * abstract * * page 70 - page 83; examples 7-10 *;
 [DY]WO9532710  (MERCK & CO INC [US], et al) [DY] 1,6-9 * abstract *;
 [A]WO9721726  (ROUSSEL UCLAF [FR], et al) [A] 1,6-9* abstract *;
 [DY]WO9937621  (HOECHST MARION ROUSSEL DE GMBH [DE], et al) [DY] 1,6-9 * page 33 - page 64; example -; claim 1 *;
 [DY]EP0960882  (HOECHST MARION ROUSSEL DE GMBH [DE], et al) [DY] 1,6-9 * page 16 - page 36; example -; claims 17-12 *
ExaminationEP0820991
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.